Literature DB >> 10650407

Bruxism and cranial-cervical dystonia: is there a relationship?

M W Watts1, E K Tan, J Jankovic.   

Abstract

To characterize the relationship between bruxism and dystonia, 79 patients (28 men and 51 women) with cranial-cervical dystonia were studied. Sixty-two patients (78.5%), 22 men and 40 women, had bruxism. The mean age at onset of dystonia in patients with bruxism was 52.4 +/- 12.6 years (range 14-80), similar to patients with cranial-cervical dystonia without bruxism. Involuntary oromandibular movements (46 patients) and blepharospasm (34 patients) were the most common initial symptoms among patients with dystonia. About one-fourth of bruxism patients had associated dental problems including TMD (21%) and tooth wear (5%). A majority (58%) of the bruxism patients had diurnal bruxism and 12% had nocturnal bruxism. The bruxism patients were compared to 100 patients with Parkinson's disease (PD), cervical dystonia, cranial dystonia, and normal controls, respectively. The prevalence of bruxism was much higher in the cranial-cervical dystonia patients when compared to normal controls (P < 0.001); however, this difference was not significant between other diseased groups and controls. Medications and botulinum toxin injections, used in the treatment of focal dystonia also provided effective relief of bruxism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10650407     DOI: 10.1080/08869634.1999.11746095

Source DB:  PubMed          Journal:  Cranio        ISSN: 0886-9634            Impact factor:   2.020


  14 in total

1.  Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study.

Authors:  Sebastian Paus; Jennifer Gross; Martina Moll-Müller; Frank Hentschel; Annika Spottke; Bettina Wabbels; Thomas Klockgether; Michael Abele
Journal:  J Neurol       Date:  2011-04-16       Impact factor: 4.849

2.  Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report.

Authors:  Andrea Santamato; Francesco Panza; Daniela Di Venere; Vincenzo Solfrizzi; Vincenza Frisardi; Maurizio Ranieri; Pietro Fiore
Journal:  J Chiropr Med       Date:  2010-09

Review 3.  Focal dystonia: the role of botulinum toxin.

Authors:  R Tintner; J Jankovic
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

4.  Botulinum toxin type A combined with cervical spine manual therapy for masseteric hypertrophy in a patient with Alzheimer-type dementia: a case report.

Authors:  Jorge H Villafañe; Cesar Fernandez-de-Las-Peñas; Paolo Pillastrini
Journal:  J Chiropr Med       Date:  2012-12

5.  Bruxism associated with anoxic encephalopathy: successful treatment with baclofen.

Authors:  A Bruce Janati; Naif Saad Alghasab; Fahad Saad Alghassab
Journal:  Case Rep Dent       Date:  2013-12-17

6.  Current Treatments of Bruxism.

Authors:  Marc Guaita; Birgit Högl
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

7.  Early effect of Botox-A injection into the masseter muscle of rats: functional and histological evaluation.

Authors:  Young-Min Moon; Young-Jun Kim; Min-Keun Kim; Seong-Gon Kim; HaeYong Kweon; Tae-Woo Kim
Journal:  Maxillofac Plast Reconstr Surg       Date:  2015-12-29

8.  Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study.

Authors:  Hessa Al-Wayli
Journal:  J Clin Exp Dent       Date:  2017-01-01

9.  Association between Temporomandibular Joint Disorder and Parkinson's Disease.

Authors:  Hyo-Geun Choi; Joo-Heung Yoon; Tae-Hwan Chung; Chanyang Min; Dae-Myoung Yoo; Jee-Hye Wee; Suk-Yun Kang; Yeso Choi; Seok-Jin Hong; Soo-Hwan Byun
Journal:  Brain Sci       Date:  2021-06-04

10.  A relationship between bruxism and orofacial-dystonia? A trigeminal electrophysiological approach in a case report of pineal cavernoma.

Authors:  Gianni Frisardi; Cesare Iani; Gianfranco Sau; Flavio Frisardi; Carlo Leornadis; Aurea Lumbau; Paolo Enrico; Donatella Sirca; Enrico Maria Staderini; Giacomo Chessa
Journal:  Behav Brain Funct       Date:  2013-10-28       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.